Virax Biolabs Group Limited (VRAX) Stock Price, Quote & News

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7788 7414

Website: viraxbiolabs.com

Address:

BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom

TwongStocks Jun. 24 at 6:54 PM

$VRAX Equity Corporate Actions Alert #2026 - 433 Information Regarding the Reverse Stock Split and CUSIP Number Change for Virax Biolabs Group Limited (VRAX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-433 Virax Biolabs Group Limited (VRAX) will effect a one-for-twenty five (1-25) reverse split of its Ordinary Shares. The reverse stock split will become effective on Friday, June 26, 2026. In conjunction with the reverse split, the CUSIP number will change to G9495L133.

0 · Reply

KobeTheGoat Jun. 24 at 4:39 PM

$VRAX 25-1 reverse split? sounds promising...let me know how many penny stock scams have been successful after a reverse split...I'll wait!!!! you bag holders do realize pump and dumps only happen once, and my friends, that was a couple years ago...since then stock went from $7+ to the current situation - STRAIGHT DOWN!!! wonder who's been here trying to teach and inform you about these SCAMS, but you didn't want to listen, continued to troll, and so I ruined your SCAM!!!! enjoy it and a 25-1 reverse split won't help you out, just speed up the inevitable process of this going to nothing!!!! STOCKS A SCAM, CEO'S A CON, AND IT'S A BOARD FULL OF BAG HOLDERS LOSING IT ALL.....weeeeeeeeeeeeeeeeeeee

1 · Reply

OliwierS Jun. 24 at 3:28 PM

$VRAX Hello, I'm in the minus 70% about 15,000 € do you think there will be a boost on July 26?

1 · Reply

focafoca99 Jun. 24 at 3:21 PM

$VRAX effective June 26 will consolidate shares 1-for-25 to meet Nasdaq $1 minimum price rule.

1 · Reply

KobeTheGoat Jun. 24 at 1:56 PM

$VRAX poo poo scam

0 · Reply

STACKD0E Jun. 24 at 1:23 PM

$VRAX $FABC $SPRU $CAN $GIBO ✨️

0 · Reply

KobeTheGoat Jun. 24 at 1:21 PM

$VRAX WHOOPSIE :-) SCAM, SCAM, SCAM

0 · Reply

AtariLynx Jun. 23 at 4:40 PM

$VRAX I feel like crying with laughter when I think about the surprise Virax will give to the shorts.

1 · Reply

KobeTheGoat Jun. 23 at 2:23 PM

$VRAX when is the delisting or reverse split or trips coming for this SCAM? where's all my new bag holders at? awfully quiet here :-) weeeeeeeeeeeeeeeeeeeeee

0 · Reply

TraderBuckNKY Jun. 23 at 1:04 PM

$VRAX • Virax Biolabs sells and distributes a wide variety of medical diagnostic test kits, primarily through its ViraxClear brand. They typically sell these kits to healthcare professionals, hospitals, and point-of-care facilities. Their test kit portfolio covers several major infectious diseases, including: • Respiratory Panels: RSV-Influenza-COVID-19 triple antigen tests and COVID-19/Influenza A+B combo kits. • Mpox (formerly Monkeypox): RT-PCR nucleic acid detection kits and rapid antigen tests. • Other Pathogens: Avian Influenza, Hepatitis B, Malaria, Herpes, and HPV. • Virax Biolabs also specializes in advanced T-Cell testing technology used for post-viral syndromes and immune profiling. • Virax distributes based on regional authorizations (such as CE marking in Europe, the Middle East, or EUA ), interested healthcare providers should reach out to their representatives directly via the ViraxClear website. For immunology research supplies - Virax Biolabs Research.

0 · Reply

Virax Biolabs approves share consolidation program

Jun 24, 2026, 9:00 AM EDT - 22 hours ago

Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation

2026-05-26T13:04:03.000Z - 4 weeks ago

Virax Biolabs reports pilot data for ViraxImmune in Long COVID

May 26, 2026, 7:30 AM EDT - 4 weeks ago

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

2026-04-14T11:58:17.000Z - 2 months ago

Virax Biolabs CEO outlines strategic priorities, near-term milestones

Apr 14, 2026, 7:34 AM EDT - 2 months ago

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

Mar 31, 2026, 7:34 AM EDT - 3 months ago

Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

2026-01-09T17:26:12.000Z - 5 months ago

Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright

2025-12-18T21:15:19.000Z - 6 months ago

Virax Biolabs files to sell 25.875M ordinary shares for holders

Dec 4, 2025, 4:05 PM EST - 7 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Dec 3, 2025, 1:53 PM EST - 7 months ago

Virax Biolabs Group Limited Announces $5 Million Private Placement

2025-12-03T13:54:57.000Z - 7 months ago

Why Is Virax Biolabs (VRAX) Stock Rocketing Higher Today?

Dec 3, 2025, 7:34 AM EST - 7 months ago

Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders

2025-11-03T13:36:20.000Z - 8 months ago

Virax completes patient recruitment for its clinical study evaluating ViraxImmun

Nov 3, 2025, 8:29 AM EST - 8 months ago

Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

2025-08-26T11:35:28.000Z - 10 months ago

Virax Biolabs partners with Emory University on ViraxImmune clinical studies

Aug 26, 2025, 7:30 AM EDT - 10 months ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Jul 29, 2025, 7:35 AM EDT - 11 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

2025-07-19T02:25:41.000Z - 1 year ago

Virax Biolabs receives noncompliance notice from Nasdaq

Jul 18, 2025, 4:15 PM EDT - 1 year ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

2025-03-31T10:15:46.000Z - 1 year ago

Virax Biolabs initiated with a Buy at H.C. Wainwright

2025-03-18T11:36:57.000Z - 1 year ago

Virax Biolabs enrolls first patients in T-cell dysfunction study

Mar 18, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 1 year ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 1 year ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 1 year ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

2025-01-13T14:41:05.000Z - 1 year ago

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

COSM

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

2024-12-10T12:35:42.000Z - 1 year ago

Virax Biolabs enters non-exclusive distribution agreement with Tebubio

Dec 10, 2024, 7:30 AM EST - 1 year ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

2024-10-23T11:35:15.000Z - 1 year ago

Virax Biolabs announces distribution agreement with Europa Biosite

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

2024-09-23T13:20:29.000Z - 1 year ago

Cosmos Health enters exclusivity agreement with Virax Biolabs

COSM

2024-09-16T12:50:07.000Z - 1 year ago

Cosmos Health secures exclusivity agreement with Virax Biolabs

COSM

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

2024-08-26T14:15:31.000Z - 1 year ago

Virax Biolabs Group Ltd trading resumes

2024-08-26T14:10:29.000Z - 1 year ago

Virax Biolabs Group Ltd trading halted, volatility trading pause

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 2 years ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 2 years ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 2 years ago

Virax Biolabs to Participate at ESCMID Global 2024

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 3 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 3 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 3 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 3 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 3 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Jan 4, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

TwongStocks Jun. 24 at 6:54 PM

0 · Reply

KobeTheGoat Jun. 24 at 4:39 PM

1 · Reply

OliwierS Jun. 24 at 3:28 PM

$VRAX Hello, I'm in the minus 70% about 15,000 € do you think there will be a boost on July 26?

1 · Reply

focafoca99 Jun. 24 at 3:21 PM

$VRAX effective June 26 will consolidate shares 1-for-25 to meet Nasdaq $1 minimum price rule.

1 · Reply

KobeTheGoat Jun. 24 at 1:56 PM

$VRAX poo poo scam

0 · Reply

STACKD0E Jun. 24 at 1:23 PM

$VRAX $FABC $SPRU $CAN $GIBO ✨️

0 · Reply

KobeTheGoat Jun. 24 at 1:21 PM

$VRAX WHOOPSIE :-) SCAM, SCAM, SCAM

0 · Reply

AtariLynx Jun. 23 at 4:40 PM

$VRAX I feel like crying with laughter when I think about the surprise Virax will give to the shorts.

1 · Reply

KobeTheGoat Jun. 23 at 2:23 PM

$VRAX when is the delisting or reverse split or trips coming for this SCAM? where's all my new bag holders at? awfully quiet here :-) weeeeeeeeeeeeeeeeeeeeee

0 · Reply

TraderBuckNKY Jun. 23 at 1:04 PM

0 · Reply

Zyne_Mu_P Jun. 22 at 9:59 PM

$VRAX wth is this pathetic drop

1 · Reply

TraderBuckNKY Jun. 21 at 12:35 PM

$VRAX Ebola outbreak in DR Congo: Health workers face challenges including shortages https://share.google/hMkYkJ1P4DeNRNE1P The world needs what VRAX has ...

1 · Reply

TraderBuckNKY Jun. 21 at 12:32 PM

$VRAX Air Force monitoring influenza outbreak among trainees at JBSA-Lackland https://share.google/uhxUUE3c7nQabljUB

0 · Reply

AtariLynx Jun. 21 at 8:57 AM

$VRAX buy at this incredible price! Gain is on the road!

1 · Reply

TraderBuckNKY Jun. 18 at 7:50 PM

$VRAX tutes and hedgies loading up soon...tommorrow a holiday for US...perfect storm brewing...

1 · Reply

AtariLynx Jun. 18 at 5:06 PM

$VRAX is preparing nice things for you bearish

1 · Reply

KobeTheGoat Jun. 18 at 2:25 PM

$VRAX SCAM

0 · Reply

Rjm5087 Jun. 18 at 12:10 PM

$VRAX R/S is inevitable at these prices.

0 · Reply

AtariLynx Jun. 17 at 8:36 PM

$PMI Let’s go PMI! The only artificial heart approved by FDA cannot disappoint! Also look at $VRAX! Debt free and working in its projects with positive results.

0 · Reply

AtariLynx Jun. 17 at 8:32 PM

$VRAX good news are coming?

0 · Reply

HoldingontoPennies Jun. 17 at 2:06 PM

$VRAX regards everywhere.

1 · Reply

Joshr1371 Jun. 17 at 2:02 PM

$VRAX

1 · Reply

Market Cap	708,000.00
Revenue (ttm)	10,000.00
Net Income (ttm)	-6.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60,600.00%
Debt to Equity Ratio	0.04

Volume	2,301,000
Avg Vol	24,093,154
Day's Range	N/A - N/A
Shares Out	4.34M
Stochastic %K	14%
Beta	1.25
Analysts	Sell
Price Target	$1.00